A Unique Case of Crossover Second Toe Syndrome treated by Autologous Peripheral Blood Stem Cells

How to Cite

Gargiulo, C., Pham, V. H., Nguyen, K. C., Vo, T. L., Duy, T. H., Abe, K., Holterman, M. J., Shiffman, M., & Filgueira, L. (2016). A Unique Case of Crossover Second Toe Syndrome treated by Autologous Peripheral Blood Stem Cells. TTU Review, 1(3). Retrieved from https://review.ttu.edu.vn/index.php/review/article/view/38


There have been many clinical designations for crossover second toe deformity, including plantar plate tears, hammertoe, metatarsalgia, predislocation syndrome and metatarsophalangeal joint (MPJ) instability. However, the crossover second toe is a common and high problematic case of foot and ankle. Mostly, the issue is associated with some form of progressive bone metabolic degenerative condition as deforming arthritis that ends with a multitude of forefoot deformities. Although multiple theories have been suggested, the true underlying cause of the deformity is multifactorial and only some of these factors have been scientifically analyzed and clarified. Thismakes the situation more problematic as the procedure requires to treat associated bone deformities, tendinopathies and neuropathies all at the same time in order to achieve a good outcome. Anatomically and pathologically this condition is a result of few condition such as the aging process, the gradual deprivation of bone structure consequently of metabolic disorders and a chronic inflammatory state as result of a prolonged increasing of medial pull of the flexor apparatus effects in rupture or attenuation of the lateral collateral ligaments of the second MPJ complex with valgus tendency exacerbating the underlying problem and inflammation. A second co-deforming force is the dorsal pull of the long and short extensor tendons without opposition from the plantar plate resulting in a hammertoe deformity with dorsal contracture or dislocation of the toe at the MPJ. Therefore it’s essential to consider soft tissue deformity together with osseous deformity in crossover second toes. Inevitably, those who treat the condition commonly note there is a long metatarsal associated with the deformity with presence of tear to the plantar soft tissue structures together with prolonged periods of high peak pressures during walk.
An adjunctive concern is due to hypermobility of the first ray linked with elevated pressures  from plantar to the second metatarsal head region. The direct pressure coupled with adductus of the hallux, which may cause dorsal displacement of the second toe, may be also be one of the basic causes of the crossover second toe.We reported a case of a 56-year-old woman presented to our formation with multiple joint osteo-arthritis with painful swelling on shoulders, bilateral knees, lower back, ankles with a visible bilateral cross over second toe condition. An MRI and X-ray were performed, and objectified a multiple osteoarthritis and grade 4 dual cross over second toe syndrome with deformity associated with hallux valgus, hallux rigidus, neuroma of the third intermetatarsal space with metatarsus sub-luxation. The patient received a treatment of autologous PB-SCs infusion during a period of 3 weeks, the results showed a complete recovery of cross over second toe condition on both left and right foot.



-DiDomenico LA, Rollandini J. A closer look at tendon transfers for crossover hammertoe. Podiatry Today. 2014;27(6).

-Thomas JL, Blitch EL, Chaney DM, Dinucci KA, Eickmeier K, Rubin LG, Stapp MD, V. Vanore JV. Diagnosis and treatment of forefoot disorders. section 1: digital deformities. J Foot Ankle Surg. 2009;48(2):230-272.

-Nery C, Coughlin MJ, Baumfeld D, Raduana F, Szejnfeld Manna T, Catenaa F. Rev Bras Ortopedia. 2015;50(6):720–728.

-Karlock LG. Second metatarsophalangeal joint fusion: a new technique for crossover hammertoe deformity. A preliminary report. J Foot Ankle Surg. 2003;42:178 –182.

- Coughlin MJ Schenck, Jr., RC Shurnas, PJ, Bloome DM. Concurrent interdigital neuroma and MTP joint instability: long-term results of treatment. Foot Ankle Int. 2002;23:1018-1025.

- Kaz AJ, Coughlin MJ: Crossover second toe: Demographics, etiology, and radiographic assessment. Foot Ankle Int., 2007;28:1223-1237.

-Deland JT, Sung IH. The medial crossover toe: a cadaveric dissection. Foot and Ankle Int. 2000;21(5):375-8.

- Higgs PE, Mackinnon SE. Repetitive motion injuries. Ann Rev Med. 1995;46:1–16.

-Hanlon DP, Luellen JR. Intersection syndrome: A case report and review of the literature. J Emergency Med. 1999;17:969–971.

- Brinks A., Koes BW., Volkers AC., Verhaar JA., Bierma-Zeinstra SM. Adverse effects of extra-articular corticosteroid injections: A systematic review. BMC Musculoskel Dis. 2010;11:206.

-Grundberg AB., Reagan DS. Pathologic anatomy of the forearm: Intersection syndrome. J Hand Surg. 1985;10(2):299–302.

-Williams JG. Surgical management of traumatic noninfective tenosynovitis of the wrist extensors. J Bone Joint Surg [Br]. 1977;59–B(4):408–410.

- Brunton LM., Wilgis EF. A survey to determine current practice patterns in the surgical treatment of advanced thumb carpometacarpal osteoarthrosis. Hand. 2010;5(4):415–422.

- The Diabetes and Nutrition Study: Group of the European Association for the Study of Diabetes (EASD): Recommendations for the nutritional management of patients with diabetes mellitus. Eur J Clin Nutr. 2000; 54:353–355.

- Radulian G, Rusu E, Dragomir A, Posea M. Metabolic effects of low glycaemic index diets. Nutr J. 2009;8:5

- Haddad SL, Sabbagh RC, Resch S, Myerson B, Myerson MS. Results of flexor-to-extensor and extensor brevis tendon transfer for correction of the crossover second toe deformity. Foot Ankle Int. 1999;20(12):781-8.

Myerson M, Jung HG. The role of toe flexor-to-extensor transfer in correcting metatarsophalangealjoint instability of the second toe. Foot Ankle Int. 2005;26:675-9.

Coughlin, MJ; Mann RA: Lesser toe deformities. In: Coughlin, MJ; Mann, RA. Surgery of the Foot and Ankle. St. Louis, Mosby 1993 pp. 372-85.

Gargiulo C, Pham VH, Nguyen TH, Nguyen CDK, Phuc PV, Abe K, Flores V, Shiffman M. Isolation and characterization of multipotent and pluripotent stem cells from human peripheral blood. J fStem Cells Disc. 2015;5:1-16.

Fehlings MG, Vawda R. Cellular treatments for spinal cord injury: the time is right for clinical trials. Neurotherapeutics. 2011;8(4):704–720.

Goldman SA. Progenitor cell-based treatment of the pediatric myelin disorders. Arch Neurology. 2011;68(7):848–856.

Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM. Evidence for a mitotic clock in human hematopoietic stem cells: Loss of telomeric DNA with age. Proc Natl Acad Sci USA. 1994;91:9857.

Shammas MA. Telomeres, lifestyle, cancer, and aging. Curr Opin Clin Nutr Metab Care. 2011;14(1): 28–34.

Correia-Melo C, Hewitt G, Passos JF. Telomeres, oxidative stress and inflammatory factors: partners in cellular senescence? Longevity Healthspan. 2014;3: 1.

Gray JW, Collins C. Genome changes and gene expression in human solid tumors. Carcinogenesis. 2000;21:443–452.

Buxton J, Suderman M, Pappas JJ, Borghol N, McArdle W, Blakemore AI, Hertzman C, Power C, Szyf M, Pembrey M.. Human leukocyte telomere length is associated with DNA methylation levels in multiple subtelomeric and imprinted loci. Sci Rep. 2014;4:4954.